Author:
Wu Yi-Hsuan,Hu Chia-Wei,Chien Chih-Wei,Chen Yu-Ju,Huang Hsuan-Cheng,Juan Hsueh-Fen
Publisher
Public Library of Science (PLoS)
Reference57 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al..GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No10. 2010. Available at globocan iarc fr.
2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004
3. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;W Pao;Proc Natl Acad Sci U S A,2004
4. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non–small-cell lung cancer: Current knowledge and future directions;W Pao;J Clin Oncol,2005
5. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non–small cell lung cancer patients treated with gefitinib or erlotinib;DM Jackman;Clin Cancer Res,2006
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献